Paul O’Nions has been in the industry since 2001, joining Novo Nordisk as a Business Intelligence analyst, progressing through various BI roles at all levels and now has a leadership position within Sanofi.

Paul has always focused on both marketing and sales information ensuring information and insight is delivered to bridge the gap between the sales, marketing and market access functions with the aim to maximise synergies that ensure marketing strategy turns into sales success. This has culminated in three BOBI awards over the years: best use of secondary data; best customer insight; and best sales effectiveness research. Key projects have included the design and implementation of segmentation and targeting strategies, key account management planning processes with integrated analytics, and sales force optimisation projects – all of which have been intrinsically linked to maximise business return.

Paul is now on the Board of the BHBIA and his primary focus is ensuring the needs of the secondary data analysts, field force excellence colleagues, CRM specialists and data visualisation professionals are heard and, more importantly, acted upon.

Jenny is currently Business Analytics and Operations Lead for Roche in the UK with a remit to champion excellence in business intelligence and lead development of data and analytics.  Jenny has an special interest in forecasting, early product development and health psychology.  She has a wealth of expertise in business intelligence gained from previous roles at AstraZeneca, GSK, SmithKline Beecham and as an independent consultant.

Kate started her career in Pharma straight out of University in 2005 where she spent time as a Project Manager for a Contract Sales Organisation – fast becoming a jack-of-all-trades for things Sales Team related. This spanned recruitment to HR and CRM systems to sales data analysis. A move within the Business Intelligence departments of one of her clients saw her skill set developed to manage key aspects of Sales Force Effectiveness (including writing and managing incentive schemes, territory structuring, sub national data analytics, CRM system development) in addition to supporting the internal Marketing, Market Access and Commercial teams with their data driven insight generation from Brand Planning to tactical execution.

Prior to setting up KES Consultancy, Kate was a Business Intelligence Analyst at AbbVie in which role she was a member of 3 cross functional brand teams within AbbVie. This not only brought challenges of managing appropriate market, strategic planning and performance data, but also managing priorities, time and stakeholder expectations.

A past attendee of various BHBIA training events over the years, and now a member of the BHBIA Board, Kate is now keen to share her own experiences of managing business questions from the aspect of the analyst. She is a passionate believer in aspiring to shift perceptions of analysts from the people with all the spreadsheets to valued business partners and advisors!

Having worked in the healthcare market research arena for most of her career, Yuliya’s passion for uncovering research insights has been supported by gaining robust experience across numerous therapy areas and methodological approaches over the years.
Through her avid interest in high quality data and a real fascination with healthcare research, Yuliya has developed extensive data collection expertise and the desire to deliver ‘gold standard’ within MR by combining the drive for innovative approaches with guideline adherence and understanding.

A naturally keen ambassador for ethical compliance and guidelines, as well as leading the implementation of GDPR within her own organisation, Yuliya joined the BHBIA Ethics & Compliance Committee in early 2018 to help drive compliance across the industry and has since spoken at two successful BHBIA GDPR events.